(Press-News.org) INDIANAPOLIS—A beta blocker typically used to treat heart problems, hemangioma, migraines and anxiety could be a new therapeutic for patients with sickle cell disease. Researchers led by Ankit A. Desai, MD, associate professor of medicine at the Krannert Cardiovascular Research Center (KCVRC) at Indiana University School of Medicine, have been awarded a $3 million grant by the U.S. Department of Defense to evaluate the efficacy of this drug.
Patients with sickle cell disease, a red blood cell disorder that can cause harm to multiple organs when red blood vessels are blocked or when the cells break down, are at risk of major complications when they also develop heart damage. The median age of death is 43 years old.
“Cardiomyopathy or heart damage can predispose patients to a fatal rhythm disturbance called ventricular tachycardia,” Desai said. “We believe that inflammation plays a key role in both, creating this injurious heart and exacerbating it. We are deeply interested in translating this potential therapeutic to patients, developing a clinical trial and trying to understand the impact R-propranolol, given that propranolol appears to be well tolerated in patients otherwise.”
Propranolol is a mixture of two chemical formulations – R-prop and S-Propranolol, which are similar in composition. The only difference is that R-prop does not demonstrate as much beta blocker activity. The team also plans to evaluate potential for toxicity before introducing R-prop in a clinical trial.
“Evaluating a therapeutic that has already been consumed by millions for other diseases could help accelerate the potential use in patients with sickle cell more quickly,” said Desai, principal investigator of the study, a cardiologist at IU Health and leader of KCVRC’s Cardiopulmonary Research Program. “This grant will allow us to study heart injury as well as rhythm disturbance impact in preclinical models of sickle cell disease. The study funds a disease that is underrecognized and underrepresented and supports a broader goal at closing health care gaps.”
Desai will collaborate with Bum-Rak Choi, PhD, associate professor of medicine at Rhode Island Hospital and Brown University. He will work closely with Choi on data related to the development of fatal arrhythmias in sickle cell disease.
“While new therapies are being explored, cleverly repurposed drugs that have already had human exposure with strong safety profile, such as R-propranolol, stand to make major headway in solving a long-standing health issue affecting the heart and cardiovascular system in the United States and abroad,” said Rohan Dharmakumar, PhD, executive director of the KCVRC.
About IU School of Medicine
IU School of Medicine is the largest medical school in the U.S. and is annually ranked among the top medical schools in the nation by U.S. News & World Report. The school offers high-quality medical education, access to leading medical research and rich campus life in nine Indiana cities, including rural and urban locations consistently recognized for livability.
END
Beta blocker used to treat heart problems and other medical concerns could be new treatment for sickle cell cardiomyopathy
2024-01-03
ELSE PRESS RELEASES FROM THIS DATE:
Cleveland Clinic and University of Western Ontario awarded $4.9 million from the Helmsley Charitable Trust to build Crohn’s disease and ileostomy research consortium
2024-01-03
Cleveland Clinic and the University of Western Ontario have been awarded a $4.9 million grant from Helmsley Charitable Trust to build a consortium to develop clinical trial outcome tools for patients with Crohn's disease and permanent ileostomy.
A permanent ileostomy is a surgical procedure to divert stool from the intestine after removing part of or the whole colon. The new Endpoint Development for Ostomy Clinical Trial (EndO-trial) Consortium seeks to develop more effective drugs for patients with Crohn's disease who have undergone ...
Researchers improve seed nitrogen content by reducing plant chlorophyll levels
2024-01-03
Chlorophyll plays a pivotal role in photosynthesis, which is why plants have evolved to have high chlorophyll levels in their leaves. However, making this pigment is expensive because plants invest a significant portion of the available nitrogen in both chlorophyll and the special proteins that bind it. As a result, nitrogen is unavailable for other processes. In a new study, researchers reduced the chlorophyll levels in leaves to see if the plant would invest the nitrogen saved into other process that might improve nutritional quality.
Over the past few decades, researchers ...
How does corrosion happen? New research examines process on atomic level
2024-01-03
BINGHAMTON, N.Y. -- When water vapor meets metal, the resulting corrosion can lead to mechanical problems that harm a machine’s performance. Through a process called passivation, it also can form a thin inert layer that acts as a barrier against further deterioration.
Either way, the exact chemical reaction is not well understood on an atomic level, but that is changing thanks to a technique called environmental transmission electron microscopy (TEM), which allows researchers to directly view molecules interacting ...
Survival of the fittest: Words like 'Sex' and 'fight' are most likely to stand the test of time
2024-01-03
New research from the University of Warwick reveals that words like 'sex' endure in our language in a ‘survival of the fittest’ way, similar to natural selection.
Whilst the recent announcement of Word of the Year explores new words, like ‘rizz’ or ‘situationship’, Professor Thomas Hills’ research delves into why some words survive in our modern linguistic landscape, while others don’t.
The study concludes that words with the strongest lasting power are:
Words acquired earlier in life
Words associated with things people can see ...
NYU Grossman School of Medicine and Sarah Lawrence College launch graduate genomics degree program
2024-01-03
NYU Grossman School of Medicine’s Vilcek Institute of Graduate Biomedical Sciences and Sarah Lawrence College today announced the launch of a master’s program in genome health analysis (GHA).
Building on the strengths of both institutions, the new program will focus on analyses of patient genomes, the complete sets of genetic information in human cells. New tools have dramatically increased the amount and quality of genomic data available on each patient, but the field is constrained by the small number of experts trained to use and apply ...
Older adults with newly diagnosed migraine disorder three times more likely to have motor vehicle crash
2024-01-03
A new study from researchers at the University of Colorado Anschutz Medical Campus finds that older adult drivers who are recently diagnosed with migraines are three times as likely to experience a motor vehicle crash. Older adult drivers who reported having ever had migraines in the past were no more likely to have a motor vehicle crash than those without migraines.
Additionally, study results, published in the Journal of the American Geriatrics Society, explored the relationships medications commonly prescribed for migraine management have with increased crash risk.
“Migraine headaches affect ...
Researchers identify circulating proteins linked to preeclampsia and other hypertensive disorders of pregnancy
2024-01-03
BOSTON – Preeclampsia and other hypertensive disorders of pregnancy—which are characterized by high blood pressure with or without organ dysfunction during the second half of pregnancy—carry considerable short- and long-term risks for both the mother and child. Treatment options (other than expedited delivery) remain limited.
A team led by researchers at Massachusetts General Hospital (MGH) and the Broad Institute recently identified several proteins with strong evidence of causal or protective roles for hypertensive disorders of pregnancy, which could provide clues into how the conditions arise and how they might be prevented or treated.
In the study, which ...
New study taps artificial intelligence to streamline the crowdsourcing of ideas
2024-01-03
INFORMS Journal Marketing Science Study Key Takeaways:
Crowdsourcing generates thousands of ideas for new products.
AI can immediately help screen out bad ideas and narrow the field to the best ones in crowdsourcing to improve efficiency.
Ultimately, AI could identify the best ideas or even design good ideas.
BALTIMORE, MD, January 3, 2024 – New research has found a way to leverage the power of artificial intelligence (AI) to more efficiently screen out bad ideas to focus on only good ideas in the crowdsourcing process within ideation. More specifically, the research has arrived at a simple model ...
UH optometrist receives $1.4 million to map the cornea
2024-01-03
Consider the cornea if you will – and most people won’t unless they’re having a problem. It is the transparent front surface of the eye which allows vision by focusing light as it enters. The cornea is densely packed with multi-tasking nerves that mediate pain, blink reflexes and tear production, all indispensable tasks in the proper maintenance of ocular surface health. Because it is highly innervated, meaning it has a lot of nerve connections, the cornea is a key area for understanding sensory functions.
But ...
Researchers identify path to prevent cognitive decline after radiation
2024-01-03
Researchers at the Del Monte Institute for Neuroscience at the University of Rochester find that microglia—the brain’s immune cells—can trigger cognitive deficits after radiation exposure and may be a key target for preventing these symptoms. These findings, out today in the International Journal of Radiation Oncology Biology Biophysics, build on previous research showing that after radiation exposure microglia damage synapses, the connections between neurons that are important for cognitive ...